D. E. Shaw & Co., Inc. Point Biopharma Global Inc. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.67 - $9.71 $198,639 - $289,173	29,781 Added 21.55%	167,955 $1.12 Million
Q2 2023 Aug 14, 2023	BUY	$6.86 - $10.86 $947,873 - $1.5 Million	138,174 New	138,174 $1.25 Million
Q2 2022 Aug 15, 2022	SELL	$5.6 - $9.5 $244,966 - $415,568	-43,744 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.46 - $8.13 $214,621 - $319,574	-39,308 Reduced 47.33%	43,744 $349,000
Q4 2021 Feb 14, 2022	BUY	$4.83 - $9.75 $97,421 - $196,657	20,170 Added 32.08%	83,052 $465,000
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $466,584 - $708,051	62,882 New	62,882 $484,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.